For overweight animals, the compound helps facilitate fat-burning while preserving muscle tissue
When done by a qualified surgeon with proper planning, it is a safe, well-established procedure
Research in preclinical models suggests that AOD 9604 may support lipolysis by upregulating beta-3 adrenergic receptor expression and inhibiting new fat cell formation, with human trial data confirming no IGF-1 elevation or glucose disruption [2, 3]
Whilst these medications are not currently licensed specifically for liver disease, growing evidence suggests they may reduce hepatic fat and improve metabolic parameters in patients with NAFLD
Both peptides are discussed for recovery support, but they work differently
This dual action on both tissue repair and digestive function makes it particularly valuable for comprehensive recovery support, including skin healing and tendon healing processes